ABSI
Absci CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$834.87M
P/E Ratio
—
EPS
$-0.82
Beta
2.38
52W High
$6.72
52W Low
$2.24
50-Day MA
$3.56
200-Day MA
$3.27
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Absci Corp
Absci Corp (ABSI) is an innovative biotechnology firm that leverages its advanced AI-driven biology platform to transform the drug discovery process. By enabling the rapid generation of high-quality proteins and therapeutic candidates, Absci minimizes development timelines and reduces costs, positioning itself as a leader in the biopharmaceutical sector. The company partners with various stakeholders to develop and manufacture next-generation therapies, emphasizing efficiency and precision. With a strong pipeline of collaborations and proprietary programs, Absci is set to make impactful contributions to modern medicine and the treatment of diseases.
Fundamentals
| Revenue (TTM) | $1.84M |
| Gross Profit (TTM) | $-81.79M |
| EBITDA | $-116.44M |
| Operating Margin | -14347.00% |
| Return on Equity | -63.90% |
| Return on Assets | -37.30% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $1.11 |
| Price-to-Book | 5.34 |
| Price-to-Sales (TTM) | 454.72 |
| EV/Revenue | 434.43 |
| EV/EBITDA | -0.39 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -81.80% |
| Shares Outstanding | $155.91M |
| Float | $146.14M |
| % Insiders | 13.02% |
| % Institutions | 69.31% |
Historical Volatility
HV 10-Day
93.29%
HV 20-Day
111.29%
HV 30-Day
94.50%
HV 60-Day
91.75%
HV Rank
76.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($8.53 target)
2
Strong Buy6
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/14/2026